Baird Medical Investment Holdings Limited (BDMD)
NASDAQ: BDMD · Real-Time Price · USD
3.310
-0.490 (-12.89%)
At close: Oct 11, 2024, 4:00 PM
3.320
+0.010 (0.31%)
After-hours: Oct 11, 2024, 7:02 PM EDT
BDMD Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Revenue | 33.05 | 26.27 | 31.46 | 23.09 | 35.09 | 188.66 | Upgrade
|
| Revenue Growth (YoY) | -82.48% | -16.48% | 36.23% | -34.19% | -81.40% | 59.50% | Upgrade
|
| Cost of Revenue | 3.83 | 3.29 | 4.23 | 4.09 | 7.05 | 31.92 | Upgrade
|
| Gross Profit | 29.22 | 22.98 | 27.23 | 19.01 | 28.04 | 156.74 | Upgrade
|
| Selling, General & Admin | 11.25 | 8.75 | 11.09 | 8.45 | 10.55 | 54.87 | Upgrade
|
| Research & Development | 4.02 | 4.05 | 4.27 | 4.57 | 3.86 | 9.77 | Upgrade
|
| Other Operating Expenses | - | - | - | - | - | 1.98 | Upgrade
|
| Operating Expenses | 15.26 | 12.8 | 15.37 | 13.02 | 14.41 | 63.99 | Upgrade
|
| Operating Income | 13.96 | 10.18 | 11.86 | 5.99 | 13.63 | 92.75 | Upgrade
|
| Interest Expense | -0.44 | -0.48 | -0.29 | -0.17 | -0.3 | -0.98 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0 | 0 | 0.01 | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | - | 0.33 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.76 | 0.01 | 0.78 | 0.05 | 1.18 | 0.9 | Upgrade
|
| EBT Excluding Unusual Items | 14.28 | 9.71 | 12.36 | 5.87 | 14.52 | 93.01 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -2.07 | Upgrade
|
| Pretax Income | 14.28 | 9.71 | 12.36 | 5.87 | 14.52 | 90.94 | Upgrade
|
| Income Tax Expense | 1.6 | 0.96 | 1.7 | 1.16 | 1.75 | 16.08 | Upgrade
|
| Earnings From Continuing Operations | 12.68 | 8.75 | 10.66 | 4.71 | 12.77 | 74.86 | Upgrade
|
| Minority Interest in Earnings | -0.13 | -0.09 | -0.11 | -0.05 | -0.21 | -0.65 | Upgrade
|
| Net Income | 12.55 | 8.66 | 10.55 | 4.66 | 12.57 | 74.21 | Upgrade
|
| Net Income to Common | 12.55 | 8.66 | 10.55 | 4.66 | 12.57 | 74.21 | Upgrade
|
| Net Income Growth | -83.09% | -17.88% | 126.27% | -62.92% | -83.06% | 60.10% | Upgrade
|
| Shares Outstanding (Basic) | 29 | 29 | 29 | 29 | 29 | 1,181 | Upgrade
|
| Shares Outstanding (Diluted) | 29 | 29 | 29 | 29 | 29 | 1,181 | Upgrade
|
| Shares Change (YoY) | -97.51% | - | - | - | -97.51% | - | Upgrade
|
| EPS (Basic) | 0.43 | 0.29 | 0.36 | 0.16 | 0.43 | 0.06 | Upgrade
|
| EPS (Diluted) | 0.43 | 0.29 | 0.36 | 0.16 | 0.43 | 0.06 | Upgrade
|
| EPS Growth | 578.78% | -17.88% | 126.27% | -62.92% | 580.02% | - | Upgrade
|
| Free Cash Flow | -7.48 | -8.89 | -3.66 | -1.24 | -5.42 | 37.64 | Upgrade
|
| Free Cash Flow Per Share | -0.25 | -0.30 | -0.12 | -0.04 | -0.18 | 0.03 | Upgrade
|
| Gross Margin | 88.41% | 87.47% | 86.56% | 82.31% | 79.90% | 83.08% | Upgrade
|
| Operating Margin | 42.23% | 38.74% | 37.71% | 25.93% | 38.85% | 49.16% | Upgrade
|
| Profit Margin | 37.96% | 32.96% | 33.52% | 20.18% | 35.82% | 39.33% | Upgrade
|
| Free Cash Flow Margin | -22.64% | -33.84% | -11.63% | -5.38% | -15.45% | 19.95% | Upgrade
|
| EBITDA | 15.13 | 11.36 | 12.85 | 6.81 | 14.49 | 97.93 | Upgrade
|
| EBITDA Margin | 45.78% | 43.25% | 40.86% | 29.50% | 41.30% | 51.91% | Upgrade
|
| D&A For EBITDA | 1.17 | 1.19 | 0.99 | 0.82 | 0.86 | 5.18 | Upgrade
|
| EBIT | 13.96 | 10.18 | 11.86 | 5.99 | 13.63 | 92.75 | Upgrade
|
| EBIT Margin | 42.23% | 38.74% | 37.71% | 25.92% | 38.85% | 49.16% | Upgrade
|
| Effective Tax Rate | 11.21% | 9.91% | 13.76% | 19.81% | 12.03% | 17.69% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.